Pub Date : 2020-01-29DOI: 10.5772/intechopen.88480
A. Sikandar, Shahzaib, N. Ullah
Thymus is a ductless, highly organized, bilobed encapsulated gland of the lymphoid organs that contributes in thymopoiesis. Thymus plays an important function in the assortment, progress and profusion of T cells. The mature subsets of thymus dependent lymphocytes linked with the thymic epithelial and other cells developed the microstructure that protect the body from the harmful foreign micro-organism. Most of the thymic lobular areas experienced the parenchymal cells hypoplasia, undergone infiltration of stromal FCT and experienced thymic atrophy with age progression. As the host gets adult, the regression of the thymus and the thymopoiesis occurs, which ultimately boost the vulnerable situations of the host and open a gateway to autoimmune diseases. Since past decades, scientists are intensely investigated to develop some tactics for the improvements of the thymus performance including T-cell regeneration and maturation with age progression. This unique organ is continuously altered morphologically with age and disease; however, this microarchitectural alteration and its possible modulations is not yet clear. Therefore, the main purpose of this chapter is to highlight the micro-structural compartments and physiological modification of the thymus with age. Also, the chapter is suggesting the possible alternative ways to improve its durable physio-morphology in vertebrates.
{"title":"Microarchitecture of the Thymus Gland; Its Age and Disease-Associated Morphological Alterations, and Possible Means to Prolong Its Physiological Activity","authors":"A. Sikandar, Shahzaib, N. Ullah","doi":"10.5772/intechopen.88480","DOIUrl":"https://doi.org/10.5772/intechopen.88480","url":null,"abstract":"Thymus is a ductless, highly organized, bilobed encapsulated gland of the lymphoid organs that contributes in thymopoiesis. Thymus plays an important function in the assortment, progress and profusion of T cells. The mature subsets of thymus dependent lymphocytes linked with the thymic epithelial and other cells developed the microstructure that protect the body from the harmful foreign micro-organism. Most of the thymic lobular areas experienced the parenchymal cells hypoplasia, undergone infiltration of stromal FCT and experienced thymic atrophy with age progression. As the host gets adult, the regression of the thymus and the thymopoiesis occurs, which ultimately boost the vulnerable situations of the host and open a gateway to autoimmune diseases. Since past decades, scientists are intensely investigated to develop some tactics for the improvements of the thymus performance including T-cell regeneration and maturation with age progression. This unique organ is continuously altered morphologically with age and disease; however, this microarchitectural alteration and its possible modulations is not yet clear. Therefore, the main purpose of this chapter is to highlight the micro-structural compartments and physiological modification of the thymus with age. Also, the chapter is suggesting the possible alternative ways to improve its durable physio-morphology in vertebrates.","PeriodicalId":76738,"journal":{"name":"Thymus","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5772/intechopen.88480","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47451588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-29DOI: 10.5772/intechopen.87063
K. Kvell
Thymic senescence develops in every person, although at different pace. Thymic senescence significantly lowers the production of naive T cells, leading to increased incidence of infections, cancer and autoimmune diseases. Certain external factors can accelerate thymic senescence. These include chemicals (copper-chelators), hor-mones (androgens), infections (viruses, fungi, protozoa). Others may slow the aging process of the thymus including perturbations to the hormonal (sex-steroid) system, genetic alterations (PPARgamma deficiency) or chemical compounds (PPARgamma antagonists). Thymic senescence research may provide insight to underlying molecular events and potentially appoint novel therapeutic targets for senescence interven-tion strategies. These hold promise to postpone thymus senescence and enhance T cell production. That would result in a decreased incidence of infections, cancer and autoimmune diseases, currently affecting the elderly. The attributed drop in healthcare costs and gain in quality of life share tremendous economic and social interest.
{"title":"Thymic Senescence","authors":"K. Kvell","doi":"10.5772/intechopen.87063","DOIUrl":"https://doi.org/10.5772/intechopen.87063","url":null,"abstract":"Thymic senescence develops in every person, although at different pace. Thymic senescence significantly lowers the production of naive T cells, leading to increased incidence of infections, cancer and autoimmune diseases. Certain external factors can accelerate thymic senescence. These include chemicals (copper-chelators), hor-mones (androgens), infections (viruses, fungi, protozoa). Others may slow the aging process of the thymus including perturbations to the hormonal (sex-steroid) system, genetic alterations (PPARgamma deficiency) or chemical compounds (PPARgamma antagonists). Thymic senescence research may provide insight to underlying molecular events and potentially appoint novel therapeutic targets for senescence interven-tion strategies. These hold promise to postpone thymus senescence and enhance T cell production. That would result in a decreased incidence of infections, cancer and autoimmune diseases, currently affecting the elderly. The attributed drop in healthcare costs and gain in quality of life share tremendous economic and social interest.","PeriodicalId":76738,"journal":{"name":"Thymus","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5772/intechopen.87063","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46529632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-11-07DOI: 10.5772/intechopen.89309
A. Sabater-Jara, María Pina Funes, M. Pedreño, S. Belchí-Navarro
Essential oils (EO) are volatile compounds produced by the secondary metabolism of aromatic plants. They are complex mixtures whose main compo nents are synthesized by the mevalonic acid and the methyl erythritol phosphate pathways, which lead to the biosynthesis of terpenes, and the shikimic acid pathway, responsible for the biosynthesis of phen ylpropanoid compounds. In nature, EOs are stored in the aerial parts of the plant, being of vital importance for their survival due to their antimicrobial properties. In addition, EOs provide protection against herbivores to the aromatic plants and allow them to repel or attract insects because of their strong fragrance, as well as compete with other plants of the same environ-ment. Humans have exploited the properties of their EOs since ancient times, being used as medicinal remedies, among other uses. Currently, aromatic plants are used in pharmaceutical and food industries. One of the most commonly used aromatic plants is thyme. Thyme is a perennial aromatic plant, taxonomically belonging to the genera Thymus and Thymbra , belonging to the family Lamiaceae. These plants are very abundant in the Mediterranean Region. In this review, we focus on the study of the properties and use of EOs of Thymbra capitata (L) Cav. and Thymus hyemalis Lange., whose EOs are rich in phenolic monoterpenes. These compounds are responsible for their antioxidant, anti-inflammatory, anticarcinogenic, antibacterial, antifungal, and antiparasitic properties.
{"title":"Essential Oils of Thymbra capitata and Thymus hyemalis and Their Uses Based on Their Bioactivity","authors":"A. Sabater-Jara, María Pina Funes, M. Pedreño, S. Belchí-Navarro","doi":"10.5772/intechopen.89309","DOIUrl":"https://doi.org/10.5772/intechopen.89309","url":null,"abstract":"Essential oils (EO) are volatile compounds produced by the secondary metabolism of aromatic plants. They are complex mixtures whose main compo nents are synthesized by the mevalonic acid and the methyl erythritol phosphate pathways, which lead to the biosynthesis of terpenes, and the shikimic acid pathway, responsible for the biosynthesis of phen ylpropanoid compounds. In nature, EOs are stored in the aerial parts of the plant, being of vital importance for their survival due to their antimicrobial properties. In addition, EOs provide protection against herbivores to the aromatic plants and allow them to repel or attract insects because of their strong fragrance, as well as compete with other plants of the same environ-ment. Humans have exploited the properties of their EOs since ancient times, being used as medicinal remedies, among other uses. Currently, aromatic plants are used in pharmaceutical and food industries. One of the most commonly used aromatic plants is thyme. Thyme is a perennial aromatic plant, taxonomically belonging to the genera Thymus and Thymbra , belonging to the family Lamiaceae. These plants are very abundant in the Mediterranean Region. In this review, we focus on the study of the properties and use of EOs of Thymbra capitata (L) Cav. and Thymus hyemalis Lange., whose EOs are rich in phenolic monoterpenes. These compounds are responsible for their antioxidant, anti-inflammatory, anticarcinogenic, antibacterial, antifungal, and antiparasitic properties.","PeriodicalId":76738,"journal":{"name":"Thymus","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-11-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5772/intechopen.89309","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47009564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-09-04DOI: 10.5772/intechopen.88588
Ildikó Bódi, K. Minkó, Z. Prodán, I. Oláh
The thymus function was discovered in the middle of the last century. The role of the thymus in the adaptive immune system facilitated its histological and experimental studies. Before the role of the thymus was discovered, the thymus was called as a gland on the basis of lobulation; even some histological textbook listed it up among the endocrine glands. In addition to the cortex and medulla, the immunohistochemical studies revealed a further compartmentalization in the thymic medulla, which is related to the epithelium-free areas (EFA) and keratin-positive network (KPN). The two medullary compartments have different cellularity that determines their role. This chapter would concentrate on the medullary compartmentalization and their cellularity. Furthermore, this chapter discusses the relationship of thymic septae with the perivascular space, the vascular embedding and thymic dendritic cells.
{"title":"Compartmentalization of Human Thymic Medulla: Facts and Hypotheses","authors":"Ildikó Bódi, K. Minkó, Z. Prodán, I. Oláh","doi":"10.5772/intechopen.88588","DOIUrl":"https://doi.org/10.5772/intechopen.88588","url":null,"abstract":"The thymus function was discovered in the middle of the last century. The role of the thymus in the adaptive immune system facilitated its histological and experimental studies. Before the role of the thymus was discovered, the thymus was called as a gland on the basis of lobulation; even some histological textbook listed it up among the endocrine glands. In addition to the cortex and medulla, the immunohistochemical studies revealed a further compartmentalization in the thymic medulla, which is related to the epithelium-free areas (EFA) and keratin-positive network (KPN). The two medullary compartments have different cellularity that determines their role. This chapter would concentrate on the medullary compartmentalization and their cellularity. Furthermore, this chapter discusses the relationship of thymic septae with the perivascular space, the vascular embedding and thymic dendritic cells.","PeriodicalId":76738,"journal":{"name":"Thymus","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5772/intechopen.88588","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46714776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-08-05DOI: 10.5772/INTECHOPEN.87132
A. R. Bijsmans, R. Cornelissen
Malignancies of the thymus are a rare entity and are often without local symptoms. However, paraneoplastic syndromes can give symptoms varying from very mild to life-threatening. The diagnostic workup and management of these tumors warrant a multidisciplinary approach. Treatment choice is mainly decided upon by pathological World Health Organization (WHO) subtype and clinical staging. In contrast to historical belief, biopsy could be considered when indicated. For resectable tumors, surgical approach is advised, with adjuvant radiotherapy for Masaoka-Koga stage III tumors. Whether Masaoka-Koga stage II tumors should be treated with radiotherapy is controversial given different outcomes in multiple studies. In Masaoka-Koga stage III, combinations with induction chemotherapy are the standard. A surgical approach should be considered even in stage IVa disease. If distant metastases are present, the patient can be treated with systemic chemotherapy. Despite many phase II studies having been published, there is no randomized controlled phase III data regarding optimal treatment available. In addition to chemotherapy, sunitinib and octreotide have been described to be effective. Immunotherapy is seen as Pandora’s box given the possibility of immune-related side effects in this immunological organ. All known data regarding immunotherapy will be discussed.
胸腺恶性肿瘤是一种罕见的疾病,通常没有局部症状。然而,副肿瘤综合征可以引起从非常轻微到危及生命的各种症状。这些肿瘤的诊断检查和管理需要多学科的方法。治疗选择主要取决于世界卫生组织(世界卫生组织)的病理亚型和临床分期。与历史上的观点相反,当需要时可以考虑活检。对于可切除的肿瘤,建议采用手术方法,对Masaoka Koga III期肿瘤进行辅助放射治疗。鉴于多项研究的不同结果,Masaoka Koga II期肿瘤是否应该接受放射治疗存在争议。在Masaoka Koga III期,联合诱导化疗是标准的。即使在IVa期疾病中,也应考虑手术入路。如果存在远处转移,患者可以进行全身化疗。尽管已经发表了许多II期研究,但没有关于最佳治疗的随机对照III期数据。除化疗外,舒尼替尼和奥曲肽也被认为是有效的。鉴于免疫器官可能出现免疫相关副作用,免疫治疗被视为潘多拉盒子。将讨论所有已知的免疫疗法数据。
{"title":"Thymoma and Thymic Carcinoma","authors":"A. R. Bijsmans, R. Cornelissen","doi":"10.5772/INTECHOPEN.87132","DOIUrl":"https://doi.org/10.5772/INTECHOPEN.87132","url":null,"abstract":"Malignancies of the thymus are a rare entity and are often without local symptoms. However, paraneoplastic syndromes can give symptoms varying from very mild to life-threatening. The diagnostic workup and management of these tumors warrant a multidisciplinary approach. Treatment choice is mainly decided upon by pathological World Health Organization (WHO) subtype and clinical staging. In contrast to historical belief, biopsy could be considered when indicated. For resectable tumors, surgical approach is advised, with adjuvant radiotherapy for Masaoka-Koga stage III tumors. Whether Masaoka-Koga stage II tumors should be treated with radiotherapy is controversial given different outcomes in multiple studies. In Masaoka-Koga stage III, combinations with induction chemotherapy are the standard. A surgical approach should be considered even in stage IVa disease. If distant metastases are present, the patient can be treated with systemic chemotherapy. Despite many phase II studies having been published, there is no randomized controlled phase III data regarding optimal treatment available. In addition to chemotherapy, sunitinib and octreotide have been described to be effective. Immunotherapy is seen as Pandora’s box given the possibility of immune-related side effects in this immunological organ. All known data regarding immunotherapy will be discussed.","PeriodicalId":76738,"journal":{"name":"Thymus","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5772/INTECHOPEN.87132","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48644819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-07-30DOI: 10.5772/INTECHOPEN.87028
A. Kouhi, Saeed Sohrabpour
The thymus, a retrosternal lymphoid tissue, develops from the third and fourth pharyngeal pouches like the parathyroid glands at the sixth week of gestational age. The thymus is usually located in the anterior mediastinum, although it can be found anywhere in the thymopharyngeal path. The thymus has a bilobed or quadrilateral shape; however, it can be found in other shapes. Limited information is available about the precise epidemiology of thymic congenital anomalies. Since these anomalies are not symptomatic, it may be more common than the available reports. There are various reports available about the prevalence of thymic diseases and anomalies ranging from 4.45 to 30%. In this chapter we tried to have a review on epidemiology, definition, and management of congenital anomalies of the thymus.
{"title":"Congenital Anomalies of the Thymus","authors":"A. Kouhi, Saeed Sohrabpour","doi":"10.5772/INTECHOPEN.87028","DOIUrl":"https://doi.org/10.5772/INTECHOPEN.87028","url":null,"abstract":"The thymus, a retrosternal lymphoid tissue, develops from the third and fourth pharyngeal pouches like the parathyroid glands at the sixth week of gestational age. The thymus is usually located in the anterior mediastinum, although it can be found anywhere in the thymopharyngeal path. The thymus has a bilobed or quadrilateral shape; however, it can be found in other shapes. Limited information is available about the precise epidemiology of thymic congenital anomalies. Since these anomalies are not symptomatic, it may be more common than the available reports. There are various reports available about the prevalence of thymic diseases and anomalies ranging from 4.45 to 30%. In this chapter we tried to have a review on epidemiology, definition, and management of congenital anomalies of the thymus.","PeriodicalId":76738,"journal":{"name":"Thymus","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5772/INTECHOPEN.87028","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46275442","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-06-20DOI: 10.5772/INTECHOPEN.87027
M. Ustarroz-Cano, Marisol López-Ángel, N. López-Valdez, I. García‐Peláez, T. Fortoul
Air pollution is a high-risk factor in megacities’ dwellers because of its effects on health. One of the most important components of the pollution is particulate matter (PM) on which metals are adhered. One element adhered to its surfaces is vanadium (V), and through this route, PM reaches the respiratory system, then the systemic circulation and the rest of the organs. Vanadium is released in the atmosphere as a consequence of the combustion of fossil fuels. Vanadium pentoxide is the com-pound liberated after the combustion and adhered into PM. Previous studies from our group have reported effects on diverse systems in a mouse model. Besides the morphological changes in the spleen and the decreased function of the immune humoral response, the thymus was also affected. Vanadium inhalation diminished thymic dendritic cells (DCs) and the biomarkers: CD11c and MHCII; in addition, thymic cytoarchitecture changed, demonstrated by cytokeratin-5, and also, modification in the expression of 3-nitrotyrosine was observed. Our findings suggest that autoreactive T cells could be released into the systemic circulation and favor the increase in autoimmune diseases in cities with high concentrations of PM.
{"title":"The Effect of Atmospheric Pollution on the Thymus","authors":"M. Ustarroz-Cano, Marisol López-Ángel, N. López-Valdez, I. García‐Peláez, T. Fortoul","doi":"10.5772/INTECHOPEN.87027","DOIUrl":"https://doi.org/10.5772/INTECHOPEN.87027","url":null,"abstract":"Air pollution is a high-risk factor in megacities’ dwellers because of its effects on health. One of the most important components of the pollution is particulate matter (PM) on which metals are adhered. One element adhered to its surfaces is vanadium (V), and through this route, PM reaches the respiratory system, then the systemic circulation and the rest of the organs. Vanadium is released in the atmosphere as a consequence of the combustion of fossil fuels. Vanadium pentoxide is the com-pound liberated after the combustion and adhered into PM. Previous studies from our group have reported effects on diverse systems in a mouse model. Besides the morphological changes in the spleen and the decreased function of the immune humoral response, the thymus was also affected. Vanadium inhalation diminished thymic dendritic cells (DCs) and the biomarkers: CD11c and MHCII; in addition, thymic cytoarchitecture changed, demonstrated by cytokeratin-5, and also, modification in the expression of 3-nitrotyrosine was observed. Our findings suggest that autoreactive T cells could be released into the systemic circulation and favor the increase in autoimmune diseases in cities with high concentrations of PM.","PeriodicalId":76738,"journal":{"name":"Thymus","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5772/INTECHOPEN.87027","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44815959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2019-05-17DOI: 10.5772/INTECHOPEN.86412
R. Thomas, D. Su
Age-related thymic atrophy or involution, a hallmark of thymic aging, takes place both in humans and animals. In this chapter, we will discuss age-related thymic atrophy, outlining the underlying cellular and molecular mechanisms of its occurrence. We will also address the downstream influences on the aged T cell immune system, not only regarding insufficiency against pathogens, but also hyper-reactivity to self. Particularly, we will focus on how thymic atrophy disrupts efficient establishment of central T cell immune tolerance primarily via impairment of thymocyte negative selection, resulting in an increased number of self-reactive conventional T cells, and on thymic-derived regulatory T cell generation. Finally, we will provide a framework for understanding the significant role that the atrophied thymus plays in shaping inflammaging: a chronic, low-grade, systemic inflammatory phenotype observed in aged individuals in the absence of acute infection. The involvement of T cell adaptive immunity in mediating inflammaging plays a crucial role in the progression of many age-related neurological and cardiovascular diseases.
{"title":"Age-Related Thymic Atrophy: Mechanisms and Outcomes","authors":"R. Thomas, D. Su","doi":"10.5772/INTECHOPEN.86412","DOIUrl":"https://doi.org/10.5772/INTECHOPEN.86412","url":null,"abstract":"Age-related thymic atrophy or involution, a hallmark of thymic aging, takes place both in humans and animals. In this chapter, we will discuss age-related thymic atrophy, outlining the underlying cellular and molecular mechanisms of its occurrence. We will also address the downstream influences on the aged T cell immune system, not only regarding insufficiency against pathogens, but also hyper-reactivity to self. Particularly, we will focus on how thymic atrophy disrupts efficient establishment of central T cell immune tolerance primarily via impairment of thymocyte negative selection, resulting in an increased number of self-reactive conventional T cells, and on thymic-derived regulatory T cell generation. Finally, we will provide a framework for understanding the significant role that the atrophied thymus plays in shaping inflammaging: a chronic, low-grade, systemic inflammatory phenotype observed in aged individuals in the absence of acute infection. The involvement of T cell adaptive immunity in mediating inflammaging plays a crucial role in the progression of many age-related neurological and cardiovascular diseases.","PeriodicalId":76738,"journal":{"name":"Thymus","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.5772/INTECHOPEN.86412","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45532121","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
J Chargui, M J Moya, K Sanhadji, N Blanc-Brunat, J L Touraine
Natural killer (NK) cells have been shown to play a role in the phenomenon of resistance to transplantation of allogeneic stem cells. To explore and prevent such resistance, we treated severe combined immunodeficiency mice (SCID) with anti-NK antibodies and analysed the improved engraftment of stem cells induced by this treatment. Two groups of nine SCID mice (H-2d) were compared: group A received two injections of anti-asialo GM1 rabbit antibodies (anti-NK) on days 1 and 4; group B received two injections of normal rabbit serum. All mice were injected intravenously with 7 x 10(6) fetal liver cells from B6 mice (H-2b) on day 2. One month after fetal liver cell transplantation, all mice from group A demonstrated engraftment and chimerism; at this time, donor cells accounted for more than 50% of peripheral blood mononuclear cells (PBMC). In contrast, in group B, only one mouse had 26% of donor cells among PBMC and all other mice had less than 10%. At two months, results were virtually identical in group A (over 72% of donor cells among PBMC from all mice) and slightly improved in group B (0-38% of donor cells). After the third month and continuously until the 12th month, the stability of chimerism was established in group A (over 55% of donor cells in 7 of the 9 mice) but had virtually disappeared in group B (0-2% of donor cells in all mice). Tissue analysis demonstrated the improved reconstitution of the thymus and the spleen in mice from group A. The proliferative responses of spleen cells to phytomitogens were significantly higher in all mice from group A than in any mouse from group B. Skin allografts from a third party (H-2k) were rejected within 10 days by group A mice but not by group B mice, one year after fetal liver cell transplantation. On the whole, anti-NK antibodies were able to improve engraftment, chimerism and stability of allogeneic stem cell transplants.
{"title":"Anti-NK antibodies injected into recipient mice enhance engraftment and chimerism after allogeneic transplantation of fetal liver stem cells.","authors":"J Chargui, M J Moya, K Sanhadji, N Blanc-Brunat, J L Touraine","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Natural killer (NK) cells have been shown to play a role in the phenomenon of resistance to transplantation of allogeneic stem cells. To explore and prevent such resistance, we treated severe combined immunodeficiency mice (SCID) with anti-NK antibodies and analysed the improved engraftment of stem cells induced by this treatment. Two groups of nine SCID mice (H-2d) were compared: group A received two injections of anti-asialo GM1 rabbit antibodies (anti-NK) on days 1 and 4; group B received two injections of normal rabbit serum. All mice were injected intravenously with 7 x 10(6) fetal liver cells from B6 mice (H-2b) on day 2. One month after fetal liver cell transplantation, all mice from group A demonstrated engraftment and chimerism; at this time, donor cells accounted for more than 50% of peripheral blood mononuclear cells (PBMC). In contrast, in group B, only one mouse had 26% of donor cells among PBMC and all other mice had less than 10%. At two months, results were virtually identical in group A (over 72% of donor cells among PBMC from all mice) and slightly improved in group B (0-38% of donor cells). After the third month and continuously until the 12th month, the stability of chimerism was established in group A (over 55% of donor cells in 7 of the 9 mice) but had virtually disappeared in group B (0-2% of donor cells in all mice). Tissue analysis demonstrated the improved reconstitution of the thymus and the spleen in mice from group A. The proliferative responses of spleen cells to phytomitogens were significantly higher in all mice from group A than in any mouse from group B. Skin allografts from a third party (H-2k) were rejected within 10 days by group A mice but not by group B mice, one year after fetal liver cell transplantation. On the whole, anti-NK antibodies were able to improve engraftment, chimerism and stability of allogeneic stem cell transplants.</p>","PeriodicalId":76738,"journal":{"name":"Thymus","volume":"24 4","pages":"233-46"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20418809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Antibodies' problem in invertebrate immunology.","authors":"M Leclerc","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":76738,"journal":{"name":"Thymus","volume":"24 3","pages":"201-2"},"PeriodicalIF":0.0,"publicationDate":"1997-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20098968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}